Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You are very welcome, RickNagra.
LOL hey everybody that's me in the Cessna plane flying around. I am about to make so much money with GRCU that I can afford to buy a pricey Cessna and fly around burning fuel and money. Great episodes from Odessa. I am saving all these episodes for my GRCU scrapbook. Eventually I will pass on this scrapbook to my kids along with my GRCU winnings. By then the PPS should be well over $5 and GRCU listed on the Nasdaq. Thanks Odessa.
Thanks DTL. We all have our own individual way to express enthusiasm for a company that we believe has the real opportunity to achieve greatness.
I've enjoyed graphic art for quite some time, so I often express my enthusiasm for an investment via graphic images.
I like the GRCU art! Fun to read as well!
Green Cures, and some thoughts on ambition...
Some have suggested that perhaps I do not have the ambition for greatness. In all fairness, that criticism may be somewhat true. After all, I only aspire to dominate the cannabis/hemp/medical mj market here on earth, rather than total domination of the entire solar system. - Hypothetical Quote
And here's the Forbes vision that I had...
GRCU
*All images are for entertainment purposes only.
•••>Something all shareholders should know about Robert Calkin...
In contrast to GRCU's employment agreements (which align the interest of shareholders with those of the company execs), several of the other OTC stocks I've owned have chosen to book a liability for the CEO's salary (i.e. salaries payable) for several quarters/years, and then the company eventually announces 'great news' via a PR that it is clearing away debt off the books.
Then those companies proceed to issue shares to the CEO to wipe the accumulated salaries payable balance off of the books. And since the stock is usually way down just prior to this 'debt satisfaction' event, the CEO ends up getting several hundred million common shares to wipe the salaries payable off of the books, because the share price is in the crapper.
If, for example, the stock was trading at .0005, a million shares would need to be issued to the CEO to satisfy each $500 owed in back salary. And 100 million shares would need to be issued to satisfy $50k in salaries payable.
By Robert Calkin accepting the static figure of 4 million shares (vested quarterly) for the 12 month period, regardless of the performance of the stock, he has demonstrated his confidence in the value of GRCU stock. And when a CEO of an OTC company demonstrates confidence and respect for the stock, the market tends to follow (because it is such a rarity in OTC land).
As always, simply my opinion.
GRCU
Thanks. And in answer to your question, absolutely.
Great episodes LOL. Looking forward to seeing more of them. Can I be in one of them as a guest appearance ?
•••>Of all the cannabis/hemp/mj related stocks, why bet on GRCU?
Those who are students of the american automotive industry know that at one time there were nearly 2000 automobile manufacturers (in late 1800s to early 1900s). There are now less than a dozen, of any consequence.
But the key to financial success is placing a bet on the one who will not only survive, but will thrive. And those that invested in the early winners were handsomely rewarded.
In some ways, the cannabis/mj industry resembles the turn-of-the-century automobile industry. Hundreds of companies have entered the space... most of whom will eventually fade away.
But I believe that Green Cures will be one of those survivors, and here's my rationale. In Robert Calkin, we have a pioneer and educator in the cannabis/mj industry. We have a CEO passionate about this industry, as evidenced by him spending several decades becoming an expert and industry guru. Additionally, he is well versed in navigating the complex and constantly changing regulatory requirements. Investment wisdom could be defined as the ability to see the building of a future empire, even as the earliest bricks are being laid.
I think we have a real winner here, and with time the charts will make that point indisputably evident.
As always, simply my opinion.
GRCU
•••>Ordinarily CNBC does not grant on-air interviews to OTC companies. But there have been exceptions. One such exception, a while back, was an energy supplement company endorsed by Tiger Woods.
I believe that just as they made an exception for the OTC supplement company because they believed that the Tiger Woods endorsement made it an interesting interview for their viewers, I could see the possibility of them being interested in interviewing Robert Calkin on-air. Keep in mind that CNBC has been airing a number of mj related specials over and over again. If they didn't believe that this topic was of interest to their viewers, they would quit airing them. Below I've listed some of the specials that CNBC has aired recently:
-Marijuana in America: Colorado Pot Rush
-Business of Marijuana: The Business
-Marijuana Inc: Inside America's Pot Industry
If Robert Calkin could land an on-air interview with CNBC, I honestly believe that Green Cures stock (GRCU) would absolutely explode to the upside. Since Mr. Calkin is a long time industry expert and navigator of cannabis/mj regulations, he would surely be of interest to that network. I would think that Bob would want to get all of his ducks in a row first, such as buttoning up the e-commerce websites and procuring enough product to meet the anticipated demand. But once that is done, I could see him reaching out to a network like CNBC to communicate the existence of this enterprise to the general investing public.
As always, simply my opinion.
GRCU
I think one of the reasons the selling pressure just above a penny is so persistent is that when the GRCU stock price makes it back to .0125, I think we will have a melt-up. And by melt-up, I mean that the top will blow off of this thing (running back toward the 52 week high of .049 and above) and shareholders will be dancing and singing so loud, law enforcement may have to issue some tickets for the noise disturbance.
As always, simply my opinion.
GRCU
One of the many notes listed as outstanding on the 8/14/14 financial statement filing is convertible debenture #41, with the following associated details:
Date: 8/1/13
Term: 12 months, 14%
Original Principal: $150,000
Unpaid Principal balance: $146,250
Conversion Price: .0025
With a conversion price of a quarter of a penny (as is stated in the 8/14/14 filing), more than 58,000,000 shares would be required to satisfy that one debenture (plus more, due to add'l accrued interest). Considering that for the past six months, the total authorized common shares was 50,000,000, that one conversion would more than double all of those previous shares.
It would seem logical that convertible debentures of that type necessitated the increase in authorized (that just took place) from 50 million to 500 million.
But worse yet, the cost basis for those additional 58,000,000 common shares will be .0025, and we are still trading (for the moment) at above a penny. That would mean that the holder of those shares would be able to begin selling shares at the current bid, and continue the selling all the way until the share price sunk to .0025, and every sell would be at a profit.
If there was not enough buying interest to absorb those sells, a prudent seller could then wait for any sort of increase from that price level to resume the selling (again, at a profit).
If doll sales were robust (and at a reasonable profit margin), OWOO could use cash to satisfy notes such as #41 I've detailed above. But logic tells me that if doll sales were currently robust, and profitable, mgmt would be proud to announce that very positive development, and would not hesitate in doing so.
So with all things considered, the very recent 10x increase in authorized common shares, combined with the unfavorable conversion terms of some of the debentures, indicates to me that we will see some significant share selling pressure in the near future. And that usually creates a downward slide in the share price. That is what I expect.
As always, simply my opinion.
OWOO
With that rationale, perhaps they should execute another 1:750 reverse split this afternoon. That way, there could be a really attractive authorized share amount of less than 1 million.
People who understand reverse splits know that they are the single most damaging catalyst to shareholder destruction in the OTC. This is why OTC sr mgmt usually reserve it as an option of last resort. It is also the reason why is very difficult to attract anything but very short term traders to buy the shares on the secondary market.
Some would say that a reverse split renders an OTC stock radioactive, sometimes for what seems like an eternity.
As always, simply my opinion.
Yeah well that's pre split. Yesterday lost are yesterday lost. Right now it's 500 million AS.
They jacked it to the equivalent of 375 billion authorized. The 1:750 reverse split, which became effective in January of this year, masked it nicely though.
Agreed, there's penny stocks that have 20 billion AS and everyone want to charge Owoo with Murder from moving there's from 50 million - 500 million. Like come on people really! I will admit though if Owoo jacked it from 50 million - 5 Billion I might have thrown some shade as well lol
Absolutely, onpoint2. lol
Hey O...HEY O IS THAT US ON THE PLANE LOOKING at THE SELLERS BELOW....
oh they are sad now.....SHOULD HAVE HELD...GRCU DA BEST UNDER .99 CENTS ! imho!
You may be right, technically speaking. We may not see .02, because we will blow right by it on the way to .03+.
i don't feel grcu will see .02
this year...
Very well stated, Wild Snapper.
mm#4 for you.
Agreed mrcheap, truly an exciting time tomorrow and moving forward.
I've been long here since Jan and although I mostly remain silent, I follow this thread daily. It's been great to follow the folks here that truly realize the full potential of what Green Cures can do.
I can't help but question how many others, like myself, have been following this stock daily and patiently been waiting for this weekend.
At this point, anyone that believes this company will fail just hasn't been reading the DD and putting the pieces together.
I believe we all will be shocked at what's to come in the next few months through the upcoming elections and into next year.
Thanks to all the longs here and just want to share my confidence and excitement in this awesome company!
The ship sails tomorrow guys!!!
“Mountaintops inspire leaders but valleys mature them.” — Winston Churchill
Robert Calkin (a seasoned veteran in this sector) is about to unveil his greatest accomplishment, cradled neatly under the umbrella of an OTC enterprise. We are very fortunate that he did not choose to do this via a privately held entity. For if he did, this opportunity to share in his success would not exist.
As always, simply my opinion.
GRCU
Just added another 500k... I believe that the product launch is closer than many believe.
FPFI
•••> With the overall downtrend during the past couple of months, it is easy to make the mistake of believing that GRCU is destined to continue the downward drift into oblivion. Although every stock has a unique chart, below I have posted the chart of another company (NTE*) which I believe demonstrates similar price movement as GRCU, and also demonstrates the upside potential once consolidation has occurred.
After bottoming at under one tenth of a penny in late Nov '12, an uptrend began in NTE* which brought it to copperland. After peaking at nearly 3 cents in early Feb '13 (up thousands of percent from the Nov bottom), it spent the next few months drifting downward, and stood at about a penny a share in mid May '13.
So after peaking at around .03, it had lost two thirds of the extraordinary gains over the next few months. At that point, those still holding had to be concerned that is might drop back into the sub-pennies never to return to copperland.
Just as with NTE*, GRCU had quickly run from tripps to multipennies, only to drift back down to about a penny a few short months later.
But just as NTE* holders were likely beginning to lose hope, those who continued to hold were in store for an extraordinary run... one that would dwarf the original run which had peaked at 3 cents. After drifting back down to the 1 cent level, NTE* went on to hit a high of 13 cents per share a couple of months later, and then ran to 17 cents per share about 4 months after that.
So my point is that after a massive move upward (such as GRCU has made), from the land of triple zeros, price consolidation is almost always a necessary evil. It allows shareholders with an entry price far lower than the current share price to be replaced with newer buyers much closer to the current price. This process, as most already know, provides a much more stable foundation, allowing for higher highs on the next run.
Although anything can happen with the respect to share price in OTC land, it is my opinion that we'll be seeing new 52 week highs for the GRCU share price within the next few months.
As always, simply my opinion.
GRCU
ACGX seems about ready to blow. Only a tick or two below the 50 day sma and 200 day sma, buys at ask about triple the volume of sells at bid, and a big revenue generating entity (multi-million per quarter). Additionally, the stock is only about a third of a cent a share.
As always, simply my opinion.
ACGX
Ordinarily CNBC does not grant on-air interviews to OTC companies. But there have been exceptions. One such exception, a while back, was an energy supplement company endorsed by Tiger Woods.
I believe that just as they made an exception for the OTC supplement company because they believed that the Tiger Woods endorsement made it an interesting interview for their viewers, I could see the possibility of them being interested in interviewing Robert Calkin on-air. Keep in mind that CNBC has been airing a number of mj related specials over and over again. If they didn't believe that this topic was of interest to their viewers, they would quit airing them. Below I've listed some of the specials that CNBC has aired recently:
-Marijuana in America: Colorado Pot Rush
-Business of Marijuana: The Business
-Marijuana Inc: Inside America's Pot Industry
If Robert Calkin could land an on-air interview with CNBC, I honestly believe that Green Cures stock (GRCU) would absolutely explode to the upside. Since Mr. Calkin is a long time industry expert and navigator of cannabis/mj regulations, he would surely be of interest to that network. I would think that Bob would want to get all of his ducks in a row first, such as buttoning up the e-commerce websites and procuring enough product to meet the anticipated demand. But once that is done, I could see him reaching out to a network like CNBC to communicate the existence of this enterprise to the general investing public.
As always, simply my opinion.
GRCU
•••>IMO, this is not a game to Robert Calkin. After decades of painstaking preparation, and now being CEO of a publicly traded entity, he will achieve greatness in this industry. And those shareholders fortunate enough to be along for the ride, will see extraordinary share price appreciation in the coming months.
As always, simply my opinion.
GRCU
Here's the genesis of the explosive price move that GRCU has had, and some of my thoughts on the subject. As painful as this price consolidation near a penny is, IMO it has been a necessary evil over the past few months, for the following reasons.
During the period of Aug 2012 thru Dec 2013, GRCU (formerly TTDZ) traded in the low triple zeros (see chart below). That's 5 complete fiscal quarters of a trading range within the low triple zeros. During that extended period of time, there was least a couple billion shares traded, which represented the entire share structure for the company.
With the entire share structure having been traded in the low triple zero range between Aug 2012 and Dec 2013, there is a very high probability that the vast majority of shareholders had an entry price in the low triple zeros, prior to the price explosion.
Within the 3 month period of Jan 1 2014 and April 1 2014, the share price then ran from .0002 to 4.9 cents. That's a 240x move, which is more than 24,000%. And since that move was preceded by trading of several billion in the low triple zeros which was more than the entire share structure, the huge move upward likely left many original shareholders with huge gains from the triple zero level.
Had the share price been in the low triple zero level only briefly (as some of the OTC stocks experience prior to a huge move), there would not be a large number of shareholder sitting on gains of tens of thousands of percent. But as we know from the historical chart (see below), there was a period well in excess of a year with the stock trading in the low triple zeros for shares to be acquired.
I think it is because of this price history that we have been seeing the stock drift downward over the past few months. I believe that on most days, there's probably a couple of million shares that were originally picked up in the low triple zeros being sold at the bid. While some are questioning why would some people be selling each day with such future potential, the answer is that even around one penny, an original low triple zero buyer is clearing 20 to 50x their original purchase amount. And with an uncertain future, and a declining stock price, who could blame them.
I do believe that most of those original buyers (with an entry point in the low triple zeros) have been flushed from the system, and we should begin to see share price appreciation in the near future.
As always simply my opinion.
GRCU
Much thanks for the compliment and endorsement, Apostle. I really think that when all of the industry dust settles, we will be standing tall. The last run will pale in comparison to where the next run, beginning from a solid base of around one penny, ends up.
A while back I captured a screen shot of the 1 yr chart on MDB% (also cannabis/mj related), where the 52 week range was 0.0287 and $215.00 Let us not forget that anything is possibly in OTC land.
As always, simply my opinion.
Great post. I encourage everyone to read it.
•••>Those who have followed the history of the american automotive industry know that at one time there were nearly 2000 automobile manufacturers (in late 1800s to early 1900s). There are now less than a dozen, of any consequence.
But the key to financial success is placing a bet on the one who will not only survive, but will thrive. And those that invested in the early winners were handsomely rewarded.
In some ways, the cannabis/mj industry resembles the turn-of-the-century automobile industry. Hundreds of companies have entered the space... most of whom will eventually fade away.
But I believe that Green Cures will be one of those survivors, and here's my rationale. In Robert Calkin, we have a pioneer and educator in the cannabis/mj industry. We have a CEO passionate about this industry, as evidenced by him spending several decades becoming an expert and industry guru. Additionally, he is well versed in navigating the complex and constantly changing regulatory requirements. Investment wisdom could be defined as the ability to see that a future empire is being built, even as the earliest bricks are being laid.
I think we have a real winner here, and with time the charts will make that point indisputably evident.
As always, simply my opinion.
GRCU
Thank you for the compliment, sampa. Some would say that I am out of my mind being so honest, when it will likely lead to further loss on the shares I still hold.
I'm willing to take that risk, to ensure that others (that may be considering an investment) know exactly what they are getting into here. That is what integrity is all about... being honest even if it may hurt you in the wallet.
As always, simply my opinion.
As always simple and brilliant Odessa99.
It does not take rocket science to put two and two together. The company has a very long list of convertible debentures. The two categories for classification of this debt are long-term and short-term. Nearly all of the debentures, as of June 30 2014, are classified as short-term debt (meaning payment will be required in the near future).
The same company has just increased the authorized common shares by a factor of 10x (from 50 million to 500 million). Common sense dictates that if the intention was to pay this large debt load (plus accrued interest) with cash, the previous share structure could have remained intact. Because as anyone invested in the OTC market knows, rarely if ever does an OTC company increase the authorized shares without already having an expectation to issue most if not all of those shares.
And when shares are issued (at a below market conversion price) to satisfy convertible debt, the downward pressure on an OTC stock can be tremendous.
As painful as it may be to acknowledge, the writing is on the wall.
As always, simply my opinion.
The stock is holding ground now, what do you estimate would happen if they got rid of those notes? I know i am reaching, but lets just dream for a second. What would happen without any pressue on the stock?
HorseShoeMan, in answer to your question: I would think that any potential offer from a major pharmaceutical company would have to be derived based upon what the acquirer saw as the wordwide market potential for the drug(s) covered under the patent(s).
This would just be a wild guess, but I would think any useful formulation patents for a common disease would be worth a minimum of tens of millions of dollars to the acquirer. And since the current market cap of MCET is only around $2 million, an offer might be in the range of 5x - 20x the current share price (so a minimum move to the range of .0035 - .015).
As always, simply my opinion.
What do you think the price would run to if that was the case here? It would only be speculation of course
•••> A $3 billion offer was tendered in 2014 for another biotech company (with minimal recent revenues to boot). Idenix is a 'biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases'. According to their 10-K filing, Idenix only had revenue of $469,000 for all of CY 2013 (see link below for filing), no revenue for Q1 or Q2 of 2014 (according to google finance), and has been bleeding money for several years.
Recently Merck tendered an offer of more than $3 billion to acquire Idenix Pharmaceuticals Inc (because of the patents they own and the research they have conducted.)
So here's an intriguing piece of info... Merck only derived about 3% of its revenue in Q1 2013 from Cancer related drugs. When an industry giant is weak in a particular area, they often use acquisitions to strengthen their weakest areas.
It would seem plausible that a company like Merck, who has already demonstrated their willingness and desire to acquire smaller companies, might eventually be willing to buy a company like MultiCell (for their research performed and patents held). And based upon the $3 billion Merck will be paying for Idenix (with little or no recent revenue), any possible offer could be rich indeed. Could you imagine how an OTC stock would react if Merck expressed some interest in owning them?
As always, simply my opinion.
Merck Completes Tender Offer to Acquire Idenix
http://www.marketwatch.com/story/merck-completes-tender-offer-to-acquire-idenix-2014-08-05
Why Did Merck Pay Such A Huge Premium For Idenix?
http://www.forbes.com/sites/greatspeculations/2014/06/12/why-did-merck-pay-such-a-huge-premium-for-idenix/
Link to Idenix Pharmaceuticals Inc 2013 10-K:
http://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/0001193125-14-073142-index.htm
MCET